D-lysyl-N-(2-{[(2R)-1-phenylpropan-2-yl]amino}ethyl)glycinamide
d-lysyl-n-(2-{[(2r)-1-phenylpropan-2-yl]amino}ethyl)glycinamide
A secondary carboxamide resulting from the formal condensation of the carboxy group of <small>D</small>-lysylglycine with the primary amino group of <em>N</em>-[(2<i>R</i>)-1-phenylpropan-2-yl]ethane-1,2-diamine. It is a hapten used in the development of an anti-methamphetamine vaccine.